首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Recombinant soluble Fc gamma RII inhibits immune complex precipitation.
【2h】

Recombinant soluble Fc gamma RII inhibits immune complex precipitation.

机译:重组可溶性FcγRII抑制免疫复合物沉淀。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Control of IgG immune complex formation and deposition is important in determining the nature and extent of subsequent immune effector responses, and appears to be aberrant in some autoimmune diseases. In this study we demonstrate that recombinant soluble Fc gamma RII (rsFc gamma RII) is an effective modulator of immune complex formation, delaying immune precipitation in a manner which is dose-dependent, and can be specifically inhibited by anti-Fc gamma RII MoAb Fab' fragments. This inhibitory role in immune precipitation also provides a possible mechanistic explanation for our previous demonstration of the efficacy of rsFc gamma RII as an inhibitor of immune complex-induced inflammation in the Arthus reaction in vivo. RsFc gamma RII inhibited immune complex precipitation in two different experimental systems. First, rsFc gamma RII inhibited the precipitation of 125I-bovine serum albumin (BSA)-anti-BSA complexes in a dose-dependent manner, while an irrelevant protein (soybean trypsin inhibitor) had no effect on the precipitation of the immune complexes. Moreover, rsFc gamma RII inhibited the precipitation of ovalbumin (OVA)-anti-OVA complexes as determined by turbidimetric analysis, where the inhibition of immune complex precipitation by rsFc gamma RII was dose-dependent and was specifically blocked by prior incubation with Fab' fragments of a blocking MoAb to Fc gamma RII. RsFc gamma RII could inhibit the precipitation of BSA-anti-BSA complexes in the presence of excess bystander IgG and did not inhibit complement-mediated prevention of immune precipitation, demonstrating that rsFc gamma RII did not block C1 binding to the BSA-anti-BSA complex. Unlike complement, rsFc gamma RII could not cause re-solubilization of pre-formed precipitated BSA-anti-BSA complexes. Soluble Fc gamma Rs have been detected in biological fluids of normal and inflammatory disease patients, yet the role of sFc gamma R is still unclear. However, they now play a potential role in the modulation of immune complex solubility.
机译:IgG免疫复合物形成和沉积的控制对于确定随后的免疫效应反应的性质和程度很重要,并且在某些自身免疫性疾病中似乎是异常的。在这项研究中,我们证明重组可溶性FcγRII(rsFcγRII)是免疫复合物形成的有效调节剂,以剂量依赖的方式延迟免疫沉淀,并且可以被抗FcγRII MoAb Fab特异性抑制的片段。在免疫沉淀中的这种抑制作用也为我们先前证明rsFcγRII作为Arthus反应体内免疫复合物诱导的炎症抑制剂的功效提供了可能的机理解释。 RsFcγRII在两个不同的实验系统中抑制免疫复合物沉淀。首先,rsFcγRII以剂量依赖的方式抑制125I-牛血清白蛋白(BSA)-抗-BSA复合物的沉淀,而无关的蛋白质(大豆胰蛋白酶抑制剂)对免疫复合物的沉淀没有影响。此外,通过比浊分析确定,rsFcγRII抑制卵白蛋白(OVA)-抗-OVA复合物的沉淀,其中rsFcγRII对免疫复合物沉淀的抑制是剂量依赖性的,并且在与Fab'片段预先孵育后被特异性阻断MoAb对FcγRII的抑制作用。在过量的旁观者IgG存在下,RsFcγRII可以抑制BSA-抗-BSA复合物的沉淀,并且不抑制补体介导的免疫沉淀的预防,表明rsFcγRII不会阻止C1与BSA-抗-BSA的结合复杂。与补体不同,rsFcγRII不会引起预形成的沉淀BSA-抗-BSA复合物的再溶解。已在正常和炎性疾病患者的生物体液中检测到可溶性FcγR,但仍不清楚sFcγR的作用。然而,它们现在在免疫复合物溶解度的调节中起潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号